Laurus Labs Share Price Target 2025, 2030, 2040, 2050

March 15, 2025 by sreestha

• CEO: Satyanarayana Chava (Jun 2007–)
• Founder: Satyanarayana Chava
• Headquarters: Hyderabad
• Number of employees: 6,007 (2025)
• Revenue: 6,040 crores INR (FY23, US$760 million)
• Subsidiaries: Laurus Generics Inc ·

Laurus Labs Share Price Target 2025 To 2050

Year	Minimum Price (₹)	Maximum Price (₹)
2025	370	900
2026	470	1060
2027	590	1220
2028	680	1360
2029	770	1470
2030	900	1694
2040	2845	3541
2050	5841	6635

Category: Stock Market

Overview of Laurus Labs Ltd (NSE: LAURUSLABS)

Laurus Labs is a prominent pharmaceutical firm based in India that specializes in producing medicines for critical diseases. The company not only manufactures APIs but also assists other companies in developing and scaling up the production of medicines. With a reputation for top-tier quality, Laurus Labs serves customers globally, cementing its position in the global pharmaceutical market.

Laurus Labs Share Price Target: Tomorrow

The stock of Laurus Labs is currently on a bullish trend, showing positive movements in the short term. Investors can expect a potential increase in stock prices as the company approaches its all-time high in the coming days. This makes it a good opportunity for short-term investments.

Day’s Price Movement Prediction

Day	Minimum Price (₹)	Maximum Price (₹)
Tomorrow	-20	+29

Laurus Labs Share Price Target 2025

In 2025, Laurus Labs is expect to continue its upward trajectory in the pharmaceutical industry. The company has made significant strides, from establishing its research center to filing patents for critical medications. The company’s global presence, along with its agreements with multinational firms, positions it for strong growth in the future. The share price target for Laurus Labs in 2025 is expect to range between ₹370 and ₹900.

Year	Minimum Price (₹)	Maximum Price (₹)
2025	370	900

Month Wise Laurus Labs Share Price Target 2025

Month	Minimum Price (₹)	Maximum Price (₹)
January	480	640
February	458	722
March	390	530
April	370	510
May	438	578
June	456	610
July	597	680
August	638	710
September	657	738
October	680	790
November	745	856
December	810	900

Also Check: 

CDSL Share Price Target 

Mobikwik Share Price Target

Trent Share Price Target

Laurus Labs Share Price Target 2026

Laurus Labs’ focus on expanding its API production and improving its position in the Contract Research and Manufacturing Services (CRAMS) market will likely drive growth in the coming years. The company’s commitment to research and development, coupled with the expansion of its global operations, positions it for long-term success. The share price target for Laurus Labs in 2026 is expect to be between ₹470 and ₹1060.

Year	Minimum Price (₹)	Maximum Price (₹)
2026	470	1060

Month Wise Laurus Labs Share Price Target 2026

Month	Minimum Price (₹)	Maximum Price (₹)
January	810	918
February	741	768
March	643	690
April	541	574
May	470	510
June	490	578
July	545	637
August	590	687
September	647	790
October	730	887
November	860	973
December	920	1060

Laurus Labs Share Price Target 2027

In 2027, Laurus Labs is expect to continue its upward momentum due to its global expansion efforts and focus on high-demand medicines such as cancer and HIV treatments. With ongoing investments in technology and innovation, the company is likely to see continued growth, provid it can manage industry competition and market conditions effectively. The share price target for Laurus Labs in 2027 is expect to be between ₹590 and ₹1220.

Year	Minimum Price (₹)	Maximum Price (₹)
2027	590	1220

Month Wise Laurus Labs Share Price Target 2027

Month	Minimum Price (₹)	Maximum Price (₹)
January	920	1079
February	810	865
March	710	757
April	632	678
May	590	655
June	628	725
July	678	780
August	738	860
September	823	968
October	928	1056
November	1011	1180
December	1145	1220

Laurus Labs Share Price Target 2028

As Laurus Labs continues to increase its production capacity and strengthen its market position in the Active Pharmaceutical Ingredient (API) sector, the company’s share price is expect to grow steadily. By expanding into new markets and investing in research, Laurus Labs is well-positioned for sustainable growth and long-term investor confidence. The share price target for Laurus Labs in 2028 is expected to be between ₹680 and ₹1360.

Year	Minimum Price (₹)	Maximum Price (₹)
2028	680	1360

Month Wise Laurus Labs Share Price Target 2028

Month	Minimum Price (₹)	Maximum Price (₹)
January	1145	1238
February	1011	1046
March	932	975
April	866	879
May	768	789
June	680	762
July	738	860
August	790	978
September	910	1078
October	1038	1176
November	1127	1278
December	1245	1360

Laurus Labs Share Price Target 2029

By 2029, Laurus Labs is expect to see further benefits from its position in the HIV/AIDS treatment market and its partnerships with international pharmaceutical companies. With strong performance in research and development, the company’s continued market dominance will likely boost investor confidence. The share price target for Laurus Labs in 2029 is expected to be between ₹770 and ₹1470.

Year	Minimum Price (₹)	Maximum Price (₹)
2029	770	1470

Month Wise Laurus Labs Share Price Target 2029

Month	Minimum Price (₹)	Maximum Price (₹)
January	1245	1387
February	1121	1174
March	1021	1078
April	910	955
May	828	845
June	770	830
July	790	858
August	825	990
September	964	1172
October	1090	1287
November	1256	1390
December	1356	1470

Laurus Labs Share Price Target 2030

Laurus Labs continues to innovate by focusing on the production of complex ingredients, especially for ARVs (antiretroviral drugs) and cancer treatments. The company’s investment in research and development, coupled with its established market presence, positions it for further growth in the coming years. The share price target for Laurus Labs in 2030 is expected to be between ₹900 and ₹1694.

Year	Minimum Price (₹)	Maximum Price (₹)
2030	900	1694

Month Wise Laurus Labs Share Price Target 2030

Month	Minimum Price (₹)	Maximum Price (₹)
January	1356	1488
February	1221	1264
March	1120	1138
April	1010	1046
May	900	990
June	950	1070
July	987	1125
August	1057	1258
September	1190	1385
October	1278	1458
November	1312	1588
December	1543	1694

Laurus Labs Share Price Target 2040

By 2040, Laurus Labs is expect to capitalize on increasing global demand for its medicines and expand further into international markets. The company’s strong position, bolstered by technological advancements and the growing healthcare sector, will help maintain its market lead. The share price target for Laurus Labs in 2040 is expected to be between ₹2845 and ₹3541.

Year	Minimum Price (₹)	Maximum Price (₹)
2040	2845	3541

Month Wise Laurus Labs Share Price Target 2040

Month	Minimum Price (₹)	Maximum Price (₹)
January	2845	2974
February	2870	2997
March	2960	3068
April	3010	3099
May	3065	3128
June	3090	3165
July	3128	3180
August	3156	3256
September	3210	3378
October	3346	3459
November	3410	3519
December	3490	3541

Laurus Labs Share Price Target 2050

Looking further into the future, Laurus Labs is project to become a leader in the development of complex ingredients for critical medicines. As the demand for ARVs and cancer treatments continues to rise, the company is expected to experience exponential growth, making it an attractive long-term investment. The share price target for Laurus Labs in 2050 is expected to range between ₹5841 and ₹6635.

Year	Minimum Price (₹)	Maximum Price (₹)
2050	5841	6635

Month Wise Laurus Labs Share Price Target 2050

Month	Minimum Price (₹)	Maximum Price (₹)
January	5841	5974
February	5876	6030
March	5968	6054
April	6010	6146
May	6121	6187
June	6146	6232
July	6198	6378
August	6257	6457
September	6378	6480
October	6423	6510
November	6456	6580
December	6538	6635

Should You Buy Laurus Labs Stock?

Laurus Labs continues to perform well, showing consistent growth and expansion. With a strong global presence and a commitment to research and development, Laurus Labs remains an attractive choice for long-term investment.

Is Laurus Labs Stock Good to Buy? (Bull case & Bear case)

Bull Case

• The company offers many different types of medicines, which helps protect it from risks if one product doesn’t do well.
• It is growing its factories and entering new markets, which could lead to more sales.
• It has been making more money every year, the past performance looks much good for this company.
• The pharmaceutical market is expected to grow because more people need healthcare.
• The company invests in research to create new and better products, helping it stay competitive.

Bear Case

• Many other companies also make generic drugs, which can limit their profits.
• If the company depends too much on a few products, any drop in demand could create problems.
• Economic Factors: Changes in the economy, like currency shifts or healthcare policies, could affect sales.
• The drug industry has strict rules. If Laurus Labs doesn’t follow them, it could face serious issues.

Is Laurus Labs a good company?

Laurus Labs is rated 4.2 out of 5 stars on AmbitionBox, based on 891 company reviews. This rating reflects a generally positive employee experience, indicating satisfaction with the company’s work culture, benefits, and career growth opportunities.

What is the salary in Laurus bio?

Salaries at Laurus Bio range from ₹3–6.2 lakh per year for junior and senior executives.

• Junior Executive: ₹3–5 lakh per year
• Senior Executive: ₹3–6.2 lakh per year

Who is the promoter of Laurus Labs?

Dr. Satyanarayana Chava and his wife Nagarani Chava are the promoters of Laurus Labs Limited. Dr. Chava is the company’s founder and CEO.